An observational study in Morbid Obesity, sponsored by IHU Strasbourg. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-09.
Sponsored by IHU Strasbourg · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Obesity, Morbid by IHU Strasbourg — 3 open to participants now, 3 under way, none of them phase 3. Obesity, Morbid · IHU Strasbourg.
Among the 10 studies in Obesity, Morbid by IHU Strasbourg, this one is the only one that started in 1996, is one of 3 observational ones, and was the 4th registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →3 of the 10 studies in Obesity, Morbid by IHU Strasbourg are open now, in 1 country. Recruiting first, the newest first:
IHU Strasbourg · Sites in France
Ages 18–75
IHU Strasbourg · Sites in France
Ages 18–65
By country, each count listing its studies:
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 1996; this study’s year is marked. 1 started in 1996.
This study's planned enrollment of 10,000 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 60 across the 7 interventional studies, 300 across the 3 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IHU Strasbourg is the lead sponsor of 44 studies on the registry; 5 are open to participants now.
2 of the studies in Obesity, Morbid by IHU Strasbourg that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02811900IHU StrasbourgAn Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study | 2026-12 |
| NCT04945473IHU StrasbourgGastric Recalibration After Endoscopic Sleeve Gastroplasty | 2027-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 10 studies in Obesity, Morbid by IHU Strasbourg, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization.
A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group).
A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization. Patients were evaluated by a multidisciplinary team. The standard preoperative assessment included nutritional counseling, psychological evaluation, abdominal ultrasound, upper gastrointestinal endoscopy, and blood tests. Type and date of surgery, biological and clinical follow-up data and morbidity data were recorded prospectively in the database.
A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group). Patients who had IH were paired with patients of the same age and sex and at the same postoperative interval. Paired patients were contacted by phone to obtain the QoL questionnaires, abdominal pain evaluation, and weight loss data.
Patient >18 years old BMI >35 kg/m²
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Laparoscopic RYGB is performed as following: a gastric pouch of approximately 30mL was obtained using successive firings of the Endo GIATM linear stapler, followed by the creation of an antecolic alimentary limb of 150cm and of a biliopancreatic limb of 75cm. A gastrojejunal anastomosis was fashioned with the PCEEA™ 28 circular stapler until 2012, and using the Endo GIA™ linear stapler afterwards. The mesenteric defect and Petersen's defect were closed using a non-absorbable running suture.
Laparoscopic SG is performed as following: after greater curvature mobilization, the gastric tube was calibrated over a 36F bougie and transection started approximately 5-6 cm from the pylorus toward the left diaphragmatic crus, using successive firings of 3.5- or 4.8-mm-high staples, depending on gastric thickness.
Laparoscopic gastric banding is performed as following: a perigastric tunel is performed by blunt dissection and the banding is calibrated over the stomach.
Flexible endoscopy is used to place intragastric balloon for a maximum interval of six months.
Excess weight loss
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
BMI
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Albumin
Albumin
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Pre-albumin
Pre-albumin
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin A
Vitamin A
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin D
Vitamin D
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B6
Vitamin B6
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B9
Vitamin B9
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B12
Vitamin B12
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Plasma ferritin
Plasma ferritin
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Fasting plasma glucose
Fasting plasma glucose
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Serum insulin
Serum insulin
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
HbA1c
HbA1c
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Triglycerides
Triglycerides
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Cholesterol
Cholesterol (total, HDL, LDL)
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Quality of life assessed by Moorehead-Ardelt Quality of life II questionnaire
Moorehead-Ardelt Quality of life II questionnaire
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Quality of life assessed by Gastro-intestinal Quality of Life Index
Gastro-intestinal Quality of Life Index
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Postoperative morbidity
Postoperative morbidity
Time frame: 1 - 3 - 5 - 10 - 15 and 30 years
Plan to share: No
The record gives a start of Jan 1996, a primary completion of Dec 2026 and a completion of Dec 2026. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IHU Strasbourg